PEN Price / Book | Penumbra, Inc

Penumbra Inc Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Penumbra Inc price/book ratio for the quarter ending 2026-06-30 was 8.11, a 5.66% increase year-over-year.
Penumbra Inc price/book ratio for the quarter ending 2026-03-31 was 8.74, a 2.89% increase year-over-year.
Penumbra Inc price/book ratio for the quarter ending 2025-12-31 was 8.54, a 7.58% increase year-over-year.
Penumbra Inc price/book ratio for the quarter ending 2025-09-30 was 7.27, a 6.33% increase year-over-year.
Penumbra Inc price/book ratio for fiscal 2026 was 8.11.
Penumbra Inc price/book ratio for fiscal 2025 was 8.54, a 7.58% increase from fiscal 2024.
Penumbra Inc price/book ratio for fiscal 2024 was 7.94, a 3.77% decline from fiscal 2023.
Penumbra Inc price/book ratio for fiscal 2023 was 8.25, a 2.76% decline from fiscal 2022.

Available history: 2015-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	8.11	$12.42B	$1.53B
2026-03-31	8.74	$12.88B	$1.47B
2025-12-31	8.54	$12.2B	$1.43B
2025-09-30	7.27	$9.87B	$1.36B
2025-06-30	7.68	$9.94B	$1.29B
2025-03-31	8.49	$10.3B	$1.21B
2024-12-31	7.94	$9.14B	$1.15B
2024-09-30	6.84	$7.55B	$1.1B
2024-06-30	6.01	$6.98B	$1.16B
2024-03-31	7.18	$8.64B	$1.2B
2023-12-31	8.25	$9.73B	$1.18B
2023-09-30	8.42	$9.3B	$1.1B
2023-06-30	12.34	$13.16B	$1.07B
2023-03-31	10.39	$10.64B	$1.02B
2022-12-31	8.49	$8.48B	$998.86M
2022-09-30	7.38	$7.18B	$973.75M
2022-06-30	4.84	$4.69B	$970.02M
2022-03-31	8.72	$8.36B	$959.3M
2021-12-31	11.32	$10.8B	$953.93M
2021-09-30	14.11	$9.75B	$690.94M
2021-03-31	15.05	$9.86B	$655.09M
2020-12-31	9.93	$6.37B	$641.5M
2020-09-30	11.28	$7.02B	$622.41M
2020-06-30	10.04	$6.27B	$624.79M
2020-03-31	11.57	$5.65B	$488.93M
2019-12-31	11.83	$5.75B	$485.89M
2019-09-30	10.01	$4.68B	$467.33M
2019-06-30	12.13	$5.51B	$454.09M
2019-03-31	11.66	$5.09B	$436.73M
2018-12-31	9.97	$4.21B	$422.24M
2018-09-30	12.57	$5.15B	$409.42M
2018-06-30	11.13	$4.73B	$425.2M
2018-03-31	9.51	$3.95B	$414.92M
2017-12-31	7.92	$3.17B	$400.41M
2017-09-30	7.95	$3.05B	$383.83M
2017-06-30	7.91	$2.95B	$372.98M
2017-03-31	7.14	$2.67B	$373.47M
2016-12-31	7.45	$1.98B	$266.55M
2016-09-30	8.95	$2.36B	$263.6M
2016-06-30	7.38	$1.83B	$247.56M
2016-03-31	5.79	$1.38B	$238.05M
2015-12-31	6.92	$1.61B	$232.52M
2015-09-30	5.24	$1.2B	$228.59M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	8.11	$12.42B	$1.53B
2025-12-31	8.54	$12.2B	$1.43B
2024-12-31	7.94	$9.14B	$1.15B
2023-12-31	8.25	$9.73B	$1.18B
2022-12-31	8.49	$8.48B	$998.86M
2021-12-31	11.32	$10.8B	$953.93M
2020-12-31	9.93	$6.37B	$641.5M
2019-12-31	11.83	$5.75B	$485.89M
2018-12-31	9.97	$4.21B	$422.24M
2017-12-31	7.92	$3.17B	$400.41M
2016-12-31	7.45	$1.98B	$266.55M
2015-12-31	6.92	$1.61B	$232.52M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BAXTER INTERNATIONAL INC (BAX)	United States	$12.139B	-10.35
Solventum Corp (SOLV)	United States	$15.085B	9.16
GLOBUS MEDICAL INC (GMED)	United States	$9.977B	20.03
INSULET CORP (PODD)	United States	$9.420B	28.12
GLAUKOS Corp (GKOS)	United States	$9.135B	-43.73
MiniMed Group, Inc. (MMED)	United States	$5.748B	-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)	United States	$5.212B	28.44
TELEFLEX INC (TFX)	United States	$5.093B	-5.44
HAEMONETICS CORP (HAE)	United States	$4.821B	36.52
Heartflow, Inc. (HTFL)	United States	$4.225B